These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36114248)

  • 1. Long-term health-related quality of life in patients with β-thalassemia after unrelated hematopoietic stem cell transplantation.
    Mulas O; Caocci G; Efficace F; Piras E; Targhetta C; Frau V; Barella S; Piroddi A; Orofino MG; Vacca A; La Nasa G
    Bone Marrow Transplant; 2022 Dec; 57(12):1833-1836. PubMed ID: 36114248
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparision of Allogeneic Hematopoietic Stem Cell Transplantation between Children with Thalassemia of Different Ages].
    Kang DL; Tan YH; Chen YM; Lu JY; Shi J; Yan XZ; Lu QY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Apr; 30(2):539-542. PubMed ID: 35395993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective assessment of health-related quality of life in pediatric patients with beta-thalassemia following hematopoietic stem cell transplantation.
    Caocci G; Efficace F; Ciotti F; Roncarolo MG; Vacca A; Piras E; Littera R; Dawood Markous RS; Collins GS; Ciceri F; Mandelli F; Marktel S; La Nasa G
    Biol Blood Marrow Transplant; 2011 Jun; 17(6):861-6. PubMed ID: 20870029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethical issues of unrelated hematopoietic stem cell transplantation in adult thalassemia patients.
    Caocci G; La Nasa G; d'Aloja E; Vacca A; Piras E; Pintor M; Demontis R; Pisu S
    BMC Med Ethics; 2011 Mar; 12():4. PubMed ID: 21385429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health-related quality of life in pediatric patients with β-thalassemia major after hematopoietic stem cell transplantation.
    Liang H; Pan L; Xie Y; Fan J; Zhai L; Liang S; Zhang Z; Lai Y
    Bone Marrow Transplant; 2022 Jul; 57(7):1108-1115. PubMed ID: 35488073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype.
    Hsieh MM; Fitzhugh CD; Weitzel RP; Link ME; Coles WA; Zhao X; Rodgers GP; Powell JD; Tisdale JF
    JAMA; 2014 Jul; 312(1):48-56. PubMed ID: 25058217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unrelated donor stem cell transplantation for transfusion-dependent thalassemia.
    Shenoy S; Thompson AA
    Ann N Y Acad Sci; 2016 Mar; 1368(1):122-6. PubMed ID: 26999376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life assessment in hematopoietic stem cell transplantation performed on thalassemia major patients.
    Uygun V; Tayfun F; Akcan M; Karasu GT; Kupesiz A; Hazar V; Yeşilipek A
    Pediatr Hematol Oncol; 2012 Aug; 29(5):461-71. PubMed ID: 22712884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of bone marrow-derived mesenchymal stem cell co-transplantation with hematopoietic stem cells on liver fibrosis alleviation and survival in patients with class III β-thalassemia major.
    Rostami T; Kasaeian A; Maleki N; Nikbakht M; Kiumarsi A; Tavangar SM; Taheri APH; Mousavi SA; Ghavamzadeh A
    Stem Cell Res Ther; 2021 Mar; 12(1):213. PubMed ID: 33781314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematopoietic Stem Cell Transplantation in Patients with Hemoglobinopathies.
    Yesilipek MA
    Hemoglobin; 2020 Nov; 44(6):377-384. PubMed ID: 33050763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unrelated Donor Peripheral Blood Stem Cell Transplantation for Patients with β-Thalassemia Major Based on a Novel Conditioning Regimen.
    Sun L; Wang N; Chen Y; Tang L; Xing C; Lu N; Shi Y; Ma Y; Lin F; Yu K; Feng J
    Biol Blood Marrow Transplant; 2019 Aug; 25(8):1592-1596. PubMed ID: 30951841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplantation for thalassemia major: alternative donors.
    Locatelli F; Merli P; Strocchio L
    Curr Opin Hematol; 2016 Nov; 23(6):515-523. PubMed ID: 27537474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Hematopoietic Stem Cell Transplantation Results in Patients with β-Thalassemia Major from Three Different Graft Types.
    Aydogdu S; Toret E; Aksoy BA; Aydın MF; Cipe FE; Bozkurt C; Fisgin T
    Hemoglobin; 2021 Jan; 45(1):25-29. PubMed ID: 33478286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matched Family versus Alternative Donor Hematopoietic Stem Cell Transplantation for Patients with Thalassemia Major: Experience from a Tertiary Referral Center in South India.
    Swaminathan VV; Uppuluri R; Patel S; Ravichandran N; Ramanan KM; Vaidhyanathan L; Ramakrishnan B; Jayakumar I; Raj R
    Biol Blood Marrow Transplant; 2020 Jul; 26(7):1326-1331. PubMed ID: 32200123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photopheresis long after the initiation of chronic graft versus host in a child.
    Uygun V; Daloglu H; Karasu G; Yeşilipek A
    Transfus Apher Sci; 2014 Oct; 51(2):172-4. PubMed ID: 25217990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thalassemia-free and graft-versus-host-free survival: outcomes of hematopoietic stem cell transplantation for thalassemia major, Turkish experience.
    Yesilipek MA; Uygun V; Kupesiz A; Karasu G; Ozturk G; Ertem M; Şaşmaz İ; Daloğlu H; Güler E; Hazar V; Fisgin T; Sezgin G; Kansoy S; Kuşkonmaz B; Akıncı B; Özbek N; İnce EÜ; Öztürkmen S; Küpesiz FT; Yalçın K; Anak S; Bozkurt C; Karakükçü M; Küpeli S; Albayrak D; Öniz H; Aksoylar S; Okur FV; Albayrak C; Yenigürbüz FD; Bozkaya İO; İleri T; Gürsel O; Karagün BŞ; Kintrup GT; Çelen S; Elli M; Aksoy BA; Yılmaz E; Tanyeli A; Akyol ŞT; Siviş ZÖ; Özek G; Uçkan D; Kartal İ; Atay D; Akyay A; Bilir ÖA; Çakmaklı HF; Kürekçi E; Malbora B; Akbayram S; Demir HA; Kılıç SÇ; Güneş AM; Zengin E; Özmen S; Antmen AB
    Bone Marrow Transplant; 2022 May; 57(5):760-767. PubMed ID: 35210564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term health-related quality of life evaluated more than 20 years after hematopoietic stem cell transplantation for thalassemia.
    La Nasa G; Caocci G; Efficace F; Dessì C; Vacca A; Piras E; Sanna M; Marcias M; Littera R; Carcassi C; Lucarelli G
    Blood; 2013 Sep; 122(13):2262-70. PubMed ID: 23958950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Haploidentical hematopoietic stem cell transplantation for beta-thalassemia major in children].
    Hao WG; Sun X; Liu S; Zhao Z; Chen ZX
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jul; 11(7):546-8. PubMed ID: 19650987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic stem cell transplantation in patients with β-thalassemia: King Faisal specialist hospital and research centre experience.
    Al-Jefri A; Ayas A; Al Musa A; Al Mahr M; Al Saleh M; Rifai S; Sabbah R; Al Seraihy A; Al Ahmari A; Khairy E; Al Hassan I; El Solh H
    Hemoglobin; 2009; 33 Suppl 1():S183-7. PubMed ID: 20001624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic/Matched Related Transplantation for β-Thalassemia and Sickle Cell Anemia.
    Bernaudin F; Pondarré C; Galambrun C; Thuret I
    Adv Exp Med Biol; 2017; 1013():89-122. PubMed ID: 29127678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.